Ventolin
ApprovedSmall molecule
AstraZenecaVentolin is one of 71 small molecule programs targeting Status Asthmaticus. It is currently in Approved.
3
Indications
5
Total Trials
0
Active Trials
70
Competitors
Pipeline
Status by Indication[3][1]
Competition
Competitive Landscape
1050 competitors in Asthma
#DrugCompanyPhaseTrials
1Ventolin
AstraZenecaApproved
Singulair
AstraZenecaPreclinical
Nucala
GGlaxo Dba Glaxosmithkline
Preclinical
Asmanex
NovartisPreclinical
Formoterol Fumarate
AstraZenecaPreclinical
Paracetamol
GSKPreclinical
Aclidinium Bromide
AstraZenecaPreclinical
Vit D
PPost Graduate Institute of Medical Education and Research, Chandigarh
Preclinical
Blood Collection
AAssistance Publique - Hôpitaux de Paris
Preclinical
Allergen Immunotherapy Extract
JJohns Hopkins University
Preclinical
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Clinical
Trials by Indication[1]
Asthma2 trials
Sources
References
- [1]
- [2]
- [3]Open Targets Platform — Drug–disease associations for Ventolin. EMBL-EBI & Wellcome Sanger Institute.
- [4]
Details
Drug Info
Quick Facts
- Modality
- Small molecule[2]
- Highest Phase
- Approved[1]
- Company